TY  - JOUR

T1  - Clinical effectiveness and cost-effectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation

JO  - HEALTH TECHNOL ASSES

UR  - http://eprints.whiterose.ac.uk/1794/

PY  - 2004/03/01

AU  - Czoski-Murray C

AU  - Warren E

AU  - Chilcott J

AU  - Beverley C

AU  - Psyllaki MA

AU  - Cowan J

ED  - 

VL  - 8

IS  - 13

SP  - 1

EP  - +

Y2  - 2024/12/22

ER  -